Amneal Pharmaceuticals (AMRX) - Cash per Share

Amneal Corp - graphic logo of issuer AMRX

Amneal Pharmaceuticals (AMRX) is developing a broad portfolio of complex generics and biosimilars for the treatment of endocrine and neurological pathologies. This cash per share chart confirms this trajectory, where the 0.50 level records fresh values. Strategic partnerships with global laboratories and a steady cash flow provide a reliable foundation for further growth and the coverage of all the company's operating expenses.

AMRX - Amneal Pharmaceuticals, Inc. Cash per Single Share over the range 07/04/2022 - 11/21/2026

Comprehensive metric breakdowns and analytics for Amneal (AMRX)

Summary company analysis:AMRX, Amneal Corp
Manufactured products of amneal.com

Fundamental risks are determined by the liquidity balance, where the current value of 0.50 reflects the actual amount of net cash per share. By analyzing the cash per share metric, an investor can assess the effectiveness of Amneal Pharmaceuticals (AMRX) expansion into the biosimilars segment, as excess capital reduces returns, while a deficit during the launch of complex drugs creates financial vulnerability.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|PRGO - Cash Funds per Share|Alvotech Corp (ALVO) - Cash per Single Share|LQDA: Cash per Share|Cash on Hand per Share glpg.com (GLPG)|Cash Funds per Share ANI Pharmaceuticals Inc|MNKD: Amount of Cash per Share|Cash per Single Share AMPH (Amphastar)|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)